Medical Education Library

CLINICAL UPDATE: Safety and Efficacy of Evolence: A Novel Injectable Dermal Filler


 

A supplement to Skin & Allergy News and supported by OrthoNeutrogena.


Faculty/Faculty Disclosures
Topics

To view the supplement, click the image above.
Faculty/Faculty Disclosures


Pearl E. Grimes, Jr., MD, Director
Vitiligo and Pigmentation Institute of Southern California
Los Angeles, Calif.
Dr. Grimes has received grant support from Johnson & Johnson.

Kenneth R. Beer, MD, FAAD
Palm Beach Esthetic Dermatology and Laser Center
West Palm Beach, Fla.
Dr.Beer has nothing to disclose.

Z. Paul Lorenc, MD, FACS
Lorenc Aesthetic Plastic Surgery
New York, N.Y.
Dr. Lorenc has nothing to disclose.

Topics

• Composition and Properties
• Clinical Data
• Summary


Copyright © 2009 by Elsevier Inc.

Recommended Reading

No Receding Interest in Beauty Treatments
MDedge Dermatology
AAD: Etanercept Safety for Children with Psoriasis Holds Up in Extension Study
MDedge Dermatology
AAD: Text Messages May Boost Atopic Dermatitis Treatment Compliance
MDedge Dermatology
Report, Summit Address the State of Autoimmune Diseases
MDedge Dermatology
More "Comparative Effectiveness" Studies Needed to Improve Quality of Care
MDedge Dermatology
Genital Herpes Remains Prevalent, Largely Undiagnosed in U.S.
MDedge Dermatology
AAD: Novel Topical Shows Promise for Atopic Dermatitis
MDedge Dermatology
Oral Ivermectin Superior to Malathion Lotion for Persistent Head Lice
MDedge Dermatology
Botanical Ingredients: Powered by Nature, Proven by ScienceTOPIC HIGHLIGHTS OF A CLINICAL ROUNDTABLE
MDedge Dermatology
Exploring the Role of Genetics In Atopic Dermatitis
MDedge Dermatology